[ Ссылка ]
A promising new drug to help psoriasis patients control their itchy, frustrating outbreaks may soon be on the way.
In two phase III clinical trials, researchers from Mount Sinai School of Medicine found that an experimental treatment for psoriasis called brodalumab may be more effective than the commonly-used psoriasis treatment ustekinumab (brand name Stelara).
Psoriasis is a chronic skin condition that changes the life cycle of skin cells, causing them to build up rapidly on the skin's surface. These extra skin cells form thick scales and itchy, dry patches that can be painful.
